No Data
No Data
Joinn Laboratories will distribute a cash dividend of 0.16 yuan per share for the 2023 annual A-share.
Joinn Laboratories (06127) announced that it will distribute a cash dividend of 0.16 yuan per share for the 2023 annual A-share on July 31, 2024.
Joinn Laboratories (06127.HK): Wuxi Jinyifu Xin Biomedical Venture Capital Partnership Enterprise Completes Record Filing Procedures.
On July 24th, Gelunhui reported that Joinn Laboratories (06127.HK) received notification on July 23, 2024 that Wuxi Jinyifu New Biomedical Entrepreneurship Investment Partnership Enterprise (Limited Partnership) had completed the filing procedures with the China Securities Investment Fund Industry Association in accordance with the requirements of the Securities Investment Fund Law and the Interim Measures for the Supervision and Administration of Private Investment Funds, and obtained the Private Investment Fund Filing Certificate. Fund name: Wuxi Jinyifu New Biomedical Entrepreneurship Investment Partnership Enterprise (Limited Partnership); Manager name: Wuxi Guolian Industrial Investment Private Equity Fund Management Co., Ltd.; Custodian name.
Joinn Laboratories (06127) will distribute an annual A-share cash dividend of 0.16 yuan per share for 2023 on July 31.
Joinn Laboratories (06127) announced that it will distribute the annual A-share dividend of 2023 per share on July 31, 2024...
Joinn Laboratories (603127.SH) will distribute a dividend of 0.16 yuan per share for the year 2023. The record date for equity is July 30th.
Joinn Laboratories (603127.SH) announced that the company will implement the annual A-share equity distribution in 2023, with a distribution of RMB per share...
Joinn Laboratories (06127): One warning of profit decline has become a market indicator. Will "rate cut" be the final key for valuation rebound?
On July 10, Joinn Laboratories (06127) closed at a record low of HK$6.62. However, the company received a boost after the release of a profit warning that evening. According to the AI Finance and Economics app, on the evening of July 10, Joinn Laboratories issued a profit warning, expecting revenue of approximately 0.719 billion yuan to 0.973 billion yuan (RMB, same below) from January to June 2024. Compared with the same period last year, it will decrease by about 38.6417 million yuan to 0.293 billion yuan, a year-on-year decline of about 3.8% to 28.9%.
JOINN Laboratories (China) Flags Losses in H1; Shares Rise 10%
No Data